Viatris Inc. faced a securities fraud lawsuit due to alleged false statements about its India facility. The FDA's actions led to a stock price drop, impacting revenue. Investors can join the lawsuit until June 3, 2025. Consider other AI stocks for potential returns.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing